𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Olfactory neuroblastoma: The results of modern treatment approaches at the University of Michigan

✍ Scribed by Dr. John J. Zappia; Dr. William R. Carroll; Dr. Gregory T. Wolf; Dr. Allan F. Thornton; Dr. Laurence Ho; Dr. Charles J. Krause

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
531 KB
Volume
15
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

A retrospective study was undertaken to review patterns of treatment and survival for patients with olfactory neuroblastomas at the University of Michigan since the introduction of craniofacial resection in the late 1970s. Recent results were cornpared to previous reports. Disease-free and overall survival for patients with Kadish stage B tumors were unchanged from prior years. Improvement in both disease-free intervals and overall survival was evident for patients with stage C tumors. Interestingly, in two patients with "unresectable" local disease, complete responses to induction chemotherapy followed by radiotherapy were noted.

πŸ“œ SIMILAR VOLUMES

The Interdisciplinary Biophysics Graduat
The Interdisciplinary Biophysics Graduate Program at the University of Michigan
✍ Ari Gafni; Nils G. Walter πŸ“‚ Article πŸ“… 2008 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 211 KB

## Abstract The Michigan Biophysics Graduate Program (MBGP) was established in 1949, making it one of the first such programs in the world. The intellectual base of the program was significantly broadened in the 1980 when faculty members from a number of other units on campus were invited to join.

Metaiodobenzylguanidine (mIBG) in treatm
Metaiodobenzylguanidine (mIBG) in treatment of 47 patients with neuroblastoma: Results of the German neuroblastoma trial
✍ Klingebiel, Thomas ;Berthold, Frank ;Treuner, JΓΆrn ;Schwabe, Dirk ;Fischer, Manf πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 502 KB

From 1984 to 1989, 47 children with relapsed, refractory, and/or metastasized neuroblastoma were treated with 131I-metaiodobenzylguanidine (mIBG) in several different treatment combinations. At initial diagnosis, 36 children had Evans stage IV and 11 stage III disease. In 16 of the 47 children, tumo